Natera, Inc. (NTRA)
Natera, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Natera, Inc. (NTRA) is a Medical - Diagnostics & Research company based in US with a market capitalization of $31.7B. Revenue grew 35.9% year-over-year and the company generated $109.1M in free cash flow. This page tracks NTRA's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 4.42K employees · IPO Jul 1, 2015
Valuation
Valuation & price
$186.36as of May 17, 2026· -28.8% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
18.52
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$31.7B
Market cap
35.9%
Revenue growth (YoY)
64.8%
Gross margin
$109.1M
Free cash flow (USD)
-$861.8M
Net debt
Net cash position
9.6%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
27
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 8, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- Insider sellJun 26, 2026Filing
Insider Sell $4.1M · 10b5-1 PlanROSENMAN HERM · Director · $4.1M
- Insider sellJun 26, 2026Filing
Insider Sell $8.5M · 10b5-1 PlanRABINOWITZ DANIEL · SEC. AND CHIEF LEGAL OFFICER · $8.5M
- Insider sellJun 22, 2026Filing
Insider Sell $330K · 10b5-1 PlanSheena Jonathan · Director · $329.8K
- Insider sellJun 17, 2026Filing
Insider Sell $665K · 10b5-1 PlanSheena Jonathan · Director · $665.1K
- Insider sellJun 17, 2026Filing
Insider Sell $643K · 10b5-1 PlanChapman Rowan E · Director · $642.5K
- Insider sellJun 16, 2026Filing
Insider Sell $21.4M · 10b5-1 PlanRabinowitz Matthew · Director, EXECUTIVE CHAIRMAN · $21.4M
- 8-K eventJun 16, 2026Filing
Equity Incentive Plan Update
- 8-K eventJun 16, 2026Filing
Director Appointment
- Insider sellJun 9, 2026Filing
Insider Sell $2.4MMarcus Gail Boxer · Director · $2.4M
- Insider sellJun 5, 2026Filing
Insider Sell $9.1M · 10b5-1 PlanChapman Steven Leonard · Director, CEO AND PRESIDENT · $9.1M
Questions
Frequently asked questions
What is Natera, Inc.'s market cap?
Natera, Inc. (NTRA) has a market capitalization of $31.7B.
What is NTRA's P/E ratio?
A meaningful P/E ratio is not available for NTRA — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is NTRA's price-to-book (P/B) ratio?
NTRA trades at 18.52 times book value per share.
Are insiders buying NTRA stock?
SEC Form 4 filings show no open-market insider buys at Natera, Inc. in the last 90 days (27 sells).
Same arena
Related companies in Medical - Diagnostics & Research
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.